Thanks,
I thought it sounded good but my platelets are still a little high; 509 on  
this test; WBC 7.9.
I can't understand why on some test there are no abnormal cells and on  other 
test there are.
It's confusing.
Thanks again,
Jeanie<3
In a message dated 2/4/2008 11:00:20 A.M. Pacific Standard Time,  
[EMAIL PROTECTED] writes:

No  abnormal cells is good.

Polyclonal is good.  It means a diverse  population of lymphocytes
instead of an expansion of a single clone  (leukemia).  Most
Lymphocytic leukemias are B-cell in  origin

Granulocytic cells are your Neutrophils, Eosinophils, and  Basophils.
No problems there.  Immature granulocytic (aka myeloid)  cells which
can be indicative of other leukemias can be detected by  flow
cytometry.

In cytometry, your cells are divided among a bunch  of tubes and test
reagents are added that have fluroescent dyes  attached.  Each tube is
labeled with the names of the tests and about  6 can be added to each
tube.  Then the cells are sucked up into the  cytometer and passed thru
a laser beam.  Cells are measured by the way  they bend the laser light
and also what type of flurescence light they  emit.

Gating is just the way the results are sorted out on the  computer.
Each cell that is analyzed on the cytometer (it can read about  10,000
a second) are stored in a computer file and its one file per  test
tube.  The technician then goes back in the computer and puts  gates
(boxes) around the cell populations and asks the computer to show  the
results just for the cells in the gate.  On a cytometer, the  cell
populations form kind of an arc on the screen with the lymphocytes  in
the lower left, the monocytes mid right, and the granulocytes in  the
upper middle to upper right.  The idea with gating is just to look  at
what is of interest depending on the test reagents that were put  into
that tube.  If the tube had no lympocyte-specific reagents in it,  then
there is no need to even count the lymphocytes in the  analysis.

A common test for clonal B-cell expansion is to test CD5 and  CD19
(CD20) in the same tube. CD5 is usually only on T-cells.  CD19 is  on
all B-cells and CD20 is only on mature B-cells.  Every person  with
Chronic Lymphocytic Leukemia will have leukemia cells that  exhibit
both CD5 and CD19 (or CD20) on the same cell.  That is not  normal.  If
each reagent was done separately, one might be able to  infer that
something was wrong since the % of B-cells in the blood was way  too
high but this simple combination confirms the diagnosis  immediately.
Cytometry can be quite useful as a screening tool of the  blood.

This report looks great.

On Feb 4, 1:01 pm,  [EMAIL PROTECTED] wrote:
> Hi all,
> Here is the results of the  FLOW CYTOMETRY REPORT done on my Peripheral  
blood.
>  IMMUNOPHENOTYPE REPORT
> SPECIMEN : Peripheral blood
>
>  INTERPRETATION
> There is no immunophenotypic evidence of an abnormal  population of  cells.
> IMMUNOPHENOTYPE (of relevant population);  Polyclonal B-lymphocytes, normal 
 
> T-lymphocytes and granulocytic  cells are identified.
> ANALYTICAL GATING:
> Gating was performed  on the granulocytic, blast, monocytic and 
lymephocytic  
>  region
> MORPHOLOGY:
> Review of the peripheral blood smear  demonstrates no evidence of  
circulating
> abnormal cells
>  CLINICAL DATA:
> The patient is a 69 year old female with history of  thrombocytosis and  
> leukocytosis
> Can someone explain  this to me.
> Thanks,
> Jeanie<3


 



**************Biggest Grammy Award surprises of all time on AOL Music.     
(http://music.aol.com/grammys/pictures/never-won-a-grammy?NCID=aolcmp003000000025
48)

--~--~---------~--~----~------------~-------~--~----~
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------

You received this message because you are subscribed to the Google Groups 
"CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to [EMAIL PROTECTED]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---

Reply via email to